December 25, 2025 05:18 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Tarique Rahman returns to Bangladesh after 17 years | Shocking killing inside AMU campus: teacher shot dead during evening walk | Horror on Karnataka highway: sleeper bus bursts into flames after truck crash, 9 killed | PM Modi attends Christmas service at Delhi church, sends message of love and compassion | Delhi erupts over lynching of Hindu man in Bangladesh; protest outside High Commission | Targeted killing sparks global outrage: American lawmakers condemn mob lynching of Hindu man in Bangladesh | Assam on a ‘powder keg’: Himanta Biswa Sarma flags demographic shift, Chicken’s Neck fears | Bangladesh on edge: Student leader shot as pre-poll violence deepens after Hadi killing | Historic deal sealed: India, New Zealand sign landmark Free Trade Agreement in record time | Supreme court snubs urgent plea to stop PMO’s chadar offering at Ajmer Sharif
Pfizer
WIKIMEDIA COMMONS

Spain expects to receive 20Mln Pfizer vaccine doses in early 2021: Spanish Health Minister

| @indiablooms | Nov 10, 2020, at 11:52 pm

Moscow/UNI: The Spanish government expects to receive 20 million doses of Pfizer vaccine by early 2021, said Spanish Health Minister Salvador Illa said on Tuesday.

Illa said that his country is planning to sign a contract with Pfizer and some other companies regarding delivery of the COVID-19 vaccine during the coming two weeks.

While speaking to the TVE channel he said that about 10 million people would be vaccinated through these vaccines "We estimate that we will receive about 20 million doses of Pfizer vaccine. It is a double dose vaccine, so about 10 million people can be vaccinated. The vaccines will be free, they will be distributed through the national health system."

The minster stated that the decision on who will receive the vaccine first would be determined by the experts from the health ministry and autonomous communities.

Illa added that there would be no problems with the delivery of the vaccine that must be kept at an ultralow temperature, as the producers guarantee the right temperature.

On Monday, German company BioNTech and its US partner Pfizer announced a successful third phase of clinical trials of the COVID-19 vaccine. It demonstrates over 90 percent efficiency in preventing the coronavirus disease, the companies said.  

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.